SCHEMBL25920244

SCHEMBL25920244

CCC(C(=O)OC)N1Cc2ccc(-c3cccc4ccncc34)cc2C1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.43
RAB9A P51151 5/20 0.43
MAPK1 P28482 9/20 0.39
KMT2A Q03164 4/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
MEN1 O00255 1/20 0.38
SDCBP O00560 1/20 0.38
SDC2 P34741 1/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP1A2 P05177 1/20 0.38
GAA P10253 1/20 0.38
CYP2D6 P10635 1/20 0.38
MAPT P10636 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
STING1 Q86WV6 1/20 0.38
LMNA P02545 1/20 0.38
PRMT5 O14744 1/20 0.37
WDR77 Q9BQA1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25920284 0.93 NPC1 (0.43) NPC1RAB9AMAPK1KMT2ASMN1; SMN2
SCHEMBL25920245 0.92 ALOX15 (0.43) MAPK1SMN1; SMN2SDCBPSDC2MAPT
SCHEMBL25918412 0.89 NPC1 (0.50) NPC1RAB9AKMT2ASMN1; SMN2NPSR1
SCHEMBL25920286 0.85 NTSR1 (0.45) MAPK1SMN1; SMN2SDCBPSDC2MAPT
SCHEMBL25919933 0.84 CYP11B1 (0.46) NPC1RAB9AMAPK1KMT2ASMN1; SMN2
SCHEMBL25918494 0.83 NPC1 (0.45) NPC1RAB9AKMT2ASMN1; SMN2NPSR1
SCHEMBL25330885 0.81 MAPK1 (0.39) MAPK1SDCBPSDC2
SCHEMBL30477327 0.81 MAPK1 (0.39) MAPK1SDCBPSDC2
SCHEMBL25918414 0.81 ALOX15 (0.50) SMN1; SMN2SDCBPSDC2ALDH1A1MAPT
SCHEMBL25920054 0.80 NPC1 (0.45) NPC1RAB9AMAPK1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023132606-A1 NOVEL ISOINDOLINONE DERIVATIVE COMPOUNDS AS CASPASE INHIBITORS 주식회사 이노보테라퓨틱스 2023-07-13 WO disclosed